bioRxivMolecular BiologyPreprint
Targeted 3'-end RNA sequencing uncovers cryptic polyadenylation in Huntington's disease linked to somatic instability and CAG repeat purity
Ane Velasco-Bilbao, María Manterola, Álvaro Herrero-Reiriz, Maria Carazo-Hidalgo, Anna Misiukiewicz, Olatz Arnold-GarcíaiD, Esther Pérez‐NavarroiD, Martina HalleggeriD, Jernej UleiD, Alberto RábanoiD, Adolfo López de MunainiD, Marta OlejniczakiD, Verónica BritoiD, Lorea BlázqueziD
Abstract
Huntingtons disease (HD) is a progressive neurodegenerative disorder caused by expanded CAG repeats in the first exon of the HTT gene, which encodes for huntingtin (HTT) protein. Full-penetrance is established at 40 repeats, but beyond, somatic repeat instability in the brain and CAG repeat purity modulate disease onset and severity. Previous studies have described that expanded repeats induce the incomplete splicing of HTT intron 1 to express the most pathogenic HTT isoform, known as HTT1a. Yet, the lack of a robust and sensitive method to evaluate HTT RNA-misprocessing has limited our understanding of HTT1a expression in HD pathophysiology. Here we describe a targeted RNA sequencing approach, known as 3-end targeted RNA sequencing or 3TRS, to simultaneously quantify multiple HTT transcripts generated by canonical and cryptic polyadenylation in several HD models. We show that activation of HTT cryptic polyadenylation is highly selective and requires long and uninterrupted CAG repeat expansions. In HD knock-in mice and human postmortem brain, cryptic HTT expression strongly correlates with brain-specific somatic repeat instability, supporting a model where ultralong and unstable CAG repeats drive toxicity by activating HTT RNA-misprocessing. Overall, 3TRS provides a robust framework to investigate HTT1a biogenesis and expression and to evaluate HTT-lowering therapeutic strategies. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=140 SRC="FIGDIR/small/697463v2_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@168d8e1org.highwire.dtl.DTLVardef@76ba3forg.highwire.dtl.DTLVardef@bdaf93org.highwire.dtl.DTLVardef@151e581_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- m6A RNA modification of mHtt intron 1 regulates the generation of Htt1a in Huntington's Disease
Anika Pupak, Irene Rodríguez-Navarro, … Verónica Brito·bioRxiv·Nov 10, 2023
- Mutant HTT protein decreases with CAG repeat expansion: implications for therapeutics and bioassays.
Christian Landles, Georgina F Osborne, … Gillian P. Bates·Brain CommunicationsPeer-reviewed·Jan 1, 2024
- Synonymous HTT CAA/CCA-loss variants associated with early Huntington disease onset enhance toxicity beyond somatic instability
Glen Lester Sequiera, Sophia C. Gjervan, … Mahmoud A. Pouladi·bioRxiv·Sep 8, 2026
- Aberrant splicing in Huntington's disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification.
Thai B. Nguyen, Ricardo Miramontes, … Leslie Michels Thompson·bioRxiv·Oct 31, 2023
- Mechanistic insights into RAN translation within the Huntingtin coding sequence
Amy Krans, Richard M. Albertson, … Peter K. Todd·bioRxiv·Sep 2, 2025
- Long somatic DNA-repeat expansion drives neurodegeneration in Huntington disease
Robert E. Handsaker, Seva Kashin, … Steven A. McCarroll·bioRxiv·May 17, 2024